Stock & Company Details
Fulcrum Therapeutics Inc $FULC
Price:
N/A
N/A
76M
$286M
52 Week High:
N/A
10 Day Average Volume:
N/A
-4.20
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
FULC technical indicators
Latest Fulcrum Therapeutics Inc (FULC) indicator readings as of 2026-10-29.
FULC's 14-day RSI is 56.6, in neutral territory. At $3.77 it is trading 36.1% below its 200-day moving average of $5.90, and above its 50-day average of $3.76. Price sits near the upper Bollinger Band ($3.63 to $3.78). ADX reads 9.4, indicating a range-bound market rather than a trend.
Overview
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. The company's proprietary product engine, FulcrumSeek, identifies drug targets that can modulate gene expression to treat the known root cause of gene mis-expression.
Finance Bot
Ask your questions
Start by typing a question below.
